Enanta Pharmaceuticals
ENTA
#7716
Rank
โ‚ฌ0.21 B
Marketcap
10,32ย โ‚ฌ
Share price
-2.47%
Change (1 day)
33.89%
Change (1 year)

P/S ratio for Enanta Pharmaceuticals (ENTA)

P/S ratio as of November 2024 (TTM): 3.26

According to Enanta Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.58. At the end of 2024 the company had a P/S ratio of 3.82.

P/S ratio history for Enanta Pharmaceuticals from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20243.8241.82%
20232.69-77.16%
202211.8-28.54%
202116.598.3%
20208.3227.67%
20196.5112.81%
20185.77-32.86%
20178.60-32.26%
201612.7169.68%
20154.71-38.15%
20147.61-92.1%
201396.3

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
6.41 96.65%๐Ÿ‡บ๐Ÿ‡ธ USA
4.27 30.95%๐Ÿ‡บ๐Ÿ‡ธ USA
12.9 294.94%๐Ÿ‡บ๐Ÿ‡ธ USA
4.17 27.84%๐Ÿ‡บ๐Ÿ‡ธ USA
2.31-28.98%๐Ÿ‡บ๐Ÿ‡ธ USA
4.26 30.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland